• Passage of SAFE Banking Act will open access to financial services for the multibillion-dollar marijuana industry
• LiveWire focusing efforts on expanding operations on path to a vertically integrated Company
• Acquisition of Estrella Ranch property, the LiveWire “Estate Grown Weedery” is “biggest accomplishment yet”

LiveWire Ergogenics Inc. (OTC: LVVV), a forward-thinking company involved in the acquisition, licensing and management of fully compliant turnkey facilities engaged in the production of high-quality cannabis-based products and services in California, is closely watching the progress of the SAFE Banking Act, which once passed on the Senate, would allow banks and credit unions to provide financial services to legal cannabis businesses. With LiveWire’s evolving role in the multibillion-dollar cannabis industry, as it develops its high-quality cannabis brands in the world’s first “Estate Grown Weedery,” the company has a keen interest in the status of legislation related to cannabis and is actively supporting further legalization efforts.

While many states have legalized cannabis for either medical or recreational (or both) use in recent years, under Federal law cannabis is still considered an illegal substance and the Federal Government has been slow to change its status. In December 2018 the U.S. Farm Bill was passed, which de-scheduled hemp as a Schedule 1 drug, although the use, sale and possession of cannabis with over 0.3 percent THC remains illegal under Federal law. Despite that reclassification, most financial institutions continue to avoid providing services to businesses operating in the cannabis space.

The Secure and Fair Enforcement (SAFE) Banking Act of 2019, HR19-1595, could change that. The bill was passed by the House of Representatives in September and then sent to the Senate, where it was referred to the Committee on Banking, Housing and Urban Affairs. According to the official summary by the Congressional Research Service, the SAFE Banking Act prohibits federal banking regulators from punishing a financial institution for offering financial services to a legal marijuana-related business

Passage of the SAFE Banking Act in the Senate and signing of the bill by the President will open access to broad financial services in the multibillion-dollar marijuana industry (http://ibn.fm/yPloj) and would clearly give legal and vertically integrated operators such as LiveWire a significant boost.

For the last few years LiveWire has been operating with a clear focus on “doing it right” in the cannabis industry. The company, via its subsidiary Estrella Ranch Partners has purchased the 265-acre Estrella Ranch property, which it plans to develop into one of the largest, vertically integrated, high-end cannabis facilities and wellness retreats in California. On the path to full vertical integration, the company is also expanding its state-wide distribution network operating under a license issued to its subsidiary GHC Ventures from The California Bureau of Cannabis Control.

“Our Estrella Ranch is probably the most beautiful piece of property and is considered a gem in the midst of the world renown California wine country,” said Bill Hodson, the CEO of LiveWire. It has the infrastructure, sufficient power, abundant water supply and the perfect micro-climate to put out the best possible high-quality product and establish a great portfolio of high-end brands. We feel that establishing the ‘Estrella Weedery’ as a central location to eventually house all our operations is our biggest accomplishment yet.”

“With the cannabis market expanding rapidly in California, we truly believe that “doing it right” will assure a sustainable success in this rapidly developing and changing cannabis industry” continued Hodson (http://ibn.fm/4EY9a). “While conducting the environmental research and maneuvering trough the complicated legal maze of laws, rules and regulations that one needs to comply with to operate legally, requires considerable resources, we are confident that getting behind a product that we know has enormous potential and establishing a high-quality brand, we will be able to rise above the noise in a turbulent market and continue to aggressively expand our presence in the cannabis market.”

Under Hodson’s leadership, LiveWire began exploring the cannabidiol (CBD) and cannabis market several years ago and has since grown into an operation with a unique portfolio of special-purpose properties focused on a variety of cannabis operations from cultivation to extraction and research for human and veterinarian applications. To continue on its path to full vertical integration, the company is also focused on expanding its statewide distribution network under a license granted by the California Bureau of Cannabis Control.

LiveWire Ergogenics specializes in identifying and monetizing current and future trends in the health and wellness industry. The company is focused on acquiring, managing, and licensing specialized, closed-loop, turnkey, cannabis, real-estate locations of fully compliant and permitted turnkey facilities to produce cannabis-based products and services in California and the statewide distribution of these products.

For more information, visit the company’s website at www.LiveWireErgogenics.com

NOTE TO INVESTORS: The latest news and updates relating to LVVV are available in the company’s newsroom at http://ibn.fm/LVVV

• Quest delivers financial, strategic and legal resources for IP monetization
• 2019 has been a productive year for Quest with six active licensing programs and 23 or more current litigations
• Quest’s strong, diversified portfolio includes 115 patents across 11 IP portfolios in a variety of markets

New York City-based intellectual property (IP) asset management company Quest Patent Research Corp. (OTCQB: QPRC) continues to deliver strong revenue growth while offering shareholders the opportunity to participate in a broad portfolio of dynamic assets (http://ibn.fm/F7BHS). In a recent interview with NetworkNewsAudio, Quest President and CEO Jon Scahill detailed the company’s focus on creating a liquid marketplace for innovation while protecting the underlying intellectual property.

“From patent prosecution, drafting, as well as issued patents, we’re pretty involved throughout the lifecycle of the invention,” Scahill stated in the interview (http://ibn.fm/LkXUU). “We pride ourselves on helping to sustain a liquid marketplace for innovation, helping investors with compelling inventions bring those to market, or finding other exit strategies.”

Quest’s commitment to helping owners monetize compelling IP can be found in a recently filed infringement case relating to the iPhone’s payments technology. The lawsuit, filed April 12 against Apple Inc. through Quest’s majority-owned and controlled subsidiary, Quest NetTech, alleges willful and deliberate infringement involving a universal financial data system technology currently in Quest’s portfolio (http://ibn.fm/hNWd2). The case is pending in the U.S. District Court for the Eastern District of Texas; Case No. 2:19-cv-00118-JRG.

As an intellectual property asset management company that delivers financial, strategic and legal resources for IP monetization, Quest partners with inventors, businesses, corporations and law firms to fully realize the value of IP assets through its suite of value-added services. Along the course of building a strong, diversified portfolio, Quest recorded $7 million in patent licensing fees in 2018.

The company currently owns, controls or manages over 115 patents across 11 intellectual property portfolios. Quest began trading on the OTCQB Venture Market in May 2019, which Scahill said in a news release (http://ibn.fm/2qvAZ) was “an exciting milestone for QPRC.”

For more information, visit the company’s website at www.QPRC.com

NOTE TO INVESTORS: The latest news and updates relating to QPRC are available in the company’s newsroom at http://ibn.fm/QPRC

• Owns or has interests in 24 cannabis retail stores throughout Canada, 65 stores expected by July 2020
• Creates personalized shopping experience through Hifyre platform, new Spark Perks membership program
• Looking to promising markets for international expansion

Fire & Flower Holdings Corp. (TSX: FAF) (OTC: FFLWF) is a leading, purpose-built, independent, adult-use cannabis retailer that provides a guided and informed experience that challenges preexisting cannabis stereotypes. Fire & Flower owns or has interests in cannabis retail-store licenses in the Canadian provinces of Alberta, Saskatchewan, Manitoba, and Ontario as well as the Yukon territory. The company currently has 24 retail stores operating in Canada with the expectation to have a total of 65 stores open by July 2020.

Fire & Flower is tackling the complex world of cannabis through education-focused, best-in-class retailing. In-store staff members called cannistas work with consumers to maximize their cannabis experience. These experts share inspiring insights, easy-to-follow advice and as much or as little education as the customer desires. The experience is heightened through the use of Hifyre(TM), a digital platform that connects visitors with cannabis products. The goal is to provide the perfect personalized experience and product every time.

Best-in-class retailing goes beyond the variety and quality of the product offered: Fire & Flower retail stores pride themselves on creating a personalized shopping experience and using technology as part of its growth strategy. The Hifyre platform is used to better understand the needs of customers and to communicate more effectively with vendor partners. Hifyre Inc. is a wholly owned subsidiary of Fire & Flower.

As a digital retail and analytics platform, Hifyre supports Fire & Flower’s advanced operations by providing a competitive advantage in understanding consumer behaviors in the rapidly changing cannabis market. Data from this platform is used to continually improve the customer experience and help guide vendor partners in curating the type of products customers want to purchase.

In September, Fire & Flower launched a new cannabis-members program throughout the company’s retail network and the Hifyre platform (http://ibn.fm/xQqBB). Called Spark Perks(TM), this new program provides members with exclusive benefits that include faster checkout, exclusive deals and content, and members-only events. As of October 28, 2019, Fire & Flower reported Spark Perks had grown to more than 38,000 members, with 33 percent of those members making more than one purchase.

Canada is set to experience a surge in derivative product launches by mid-December since “legalization 2.0” is now officially in effect. The market in Canada is changing rapidly, and with those changes comes new terminology, accessories, acceptance and culture. Fire & Flower is working to guide consumers through these changes in an enjoyable, stress-relieving way.

Keeping time with the evolving market, Fire & Flower CEO Trevor Fencott refers to the company’s business model as “retail 2.0” and reported that “since the launch of the Spark Perks program, Fire & Flower has seen an increase in customer engagement and basket size of members across our retail network. The launch of the Spark Perks member program demonstrates Fire & Flower’s continued commitment to be a leading data-driven, ‘retail 2.0’ company.”

Derivatives are a more intriguing way to reach a younger generation of consumers and could provide Fire & Flower with products that come with significantly higher margins. A spending breakdown of derivatives shows that dried flower, already a main component of Fire & Flower’s retail, is projected to remain the leading source of sales at 43 percent, followed by vape pens at 23 percent, edibles and beverages at 13 percent, concentrations at nine percent and pre-rolls at seven percent (http://ibn.fm/lStpc). For now, Fire & Flower online retail consists of dried flowers, cannabis oil, accessories and apparel.

As the cannabis industry continues to grow, Fire & Flower has its eyes on the global market. Fencott, who is looking at Canada as “a microcosm of the global scene,” has a 24-month execution plan to max out the opportunity share in Canada and is considering other promising markets as international expansion prospects (http://ibn.fm/KVmXt).

For more information, visit the company’s website at www.FireandFlower.com

• BEV partners with Capna; signs LOI to manufacture, possess and sell vape products in Canada
• Company to sell products legally under license from Health Canada
• Cannabis, CBD and hemp-infused drinks market estimated to hit $1.4 billion by 2024 in the U.S.

BevCanna Enterprises Inc. (CSE: BEV) (OTC: BVNNF) (FRA: 7BC) has signed an LOI with high-profile cannabis operator Capna Intellectual Inc., the production partner of Bloom, to bring the Bloom brand, including its vaping products, to Canada. Both BEV and Capna are working towards a definitive agreement calling for BEV to manufacture, possess and sell Bloom cannabis products, such as vaping cartridges and disposables, as it receives licensing approval from Health Canada (http://ibn.fm/QsDn7).

The agreement also calls for BEV to sell other cannabis products including cannabis concentrates and extracts on behalf of Capna. In addition, BevCanna would be granted an exclusive license for certain technology and branding assets in Canada in connection with its manufacturing of cannabis products for Capna.

As part of the agreement, BEV subscribed for $250,000 of 135,747 preferred Seed Series Preferred Shares in the capital of Capna. Upon signing the definitive agreement, Bev expects to subscribe for another $250,000 in Capna shares.

“The JV with Bloom is an excellent opportunity for BevCanna to partner with a strong, reputable brand in the vape category,” said BevCanna chief communications officer Emma Andrews. “Canadians are eager to see more vape options from trustworthy retailers, and we’re excited to be able to provide that.”

In addition to BevCanna being the exclusive distributor for Capna in Canada, the partnership also calls for the company to be the exclusive distributor in California if Capna should enter the beverage market. BEV would also hold first right of refusal to be exclusive beverage manufacturer in any other U.S. state should Capna expand its products to the beverage space.

The move puts BEV at the intersection of two growing cannabis sectors: cannabis-infused beverages and vaping. In the United States, the cannabis-infused beverage market, including cannabis, CBD and hemp, is forecast to reach $1.4 billion by 2024, according to consultant Zenith Global (http://ibn.fm/1NvRD). That represents an incredible jump of almost 15 times from the estimated $89 million the category represented in 2018.

Vaping in Canada, now legal, is also seen as a potentially lucrative market for legal companies in this sector. The Cannabis Council of Canada estimates that the illicit market in vaping in Canada prior to legalization was an estimated $1 billion. As a legal market today, the space is regulated by Health Canada, which officially licenses producers of vape products, edibles, extracts and topical.

Based in British Columbia, Canada, BevCanna develops and manufactures cannabis-infused beverages and consumer products for white-label clients and in-house brands. The company’s common shares began trading on the Canadian Securities Exchange last July. BevCanna’s vision is to become a global leader in infused innovations, and its recent moves have positioned it well for growth in multiple burgeoning sectors.

For more information, visit the company’s website at www.BevCanna.com

• Spectrum expands ADEX subsidiary into Canada
• Company continues international operations in Puerto Rico, U.S. mainland, Hawaii, and U.S. Virgin Islands
• SGSI wins key two-year, nationwide, engineering-services contract to support 5G deployment by tier-1 infrastructure aggregator

A recent announcement from Spectrum Global Solutions Inc. (OTCQB: SGSI) shows the company is getting down to business in Canada. Spectrum is expanding its ADEX subsidiary into Canada as part of the company’s continued international expansion efforts.

It appears to be the ideal time. Canada is racing ahead with 5G, with the University of British Columbia (UBC) carrying the torch. The renowned research academic institution has become the first 5G-smart campus in Canada, according to one news report, a move likely to turn into a trend (http://ibn.fm/E9Snq). As Canadian 5G implementation continues, Spectrum is stepping up deployment of its spectrum of telecommunications services. The company owns and operates several subsidiaries — ADEX Corporation, AW Solutions, Tropical Communications and TNS — that allow it to provide comprehensive solutions covering all aspects of wireless and fiber networks and infrastructure.

Spectrum acquired ADEX Corporation, an Alpharetta, Georgia-based company, and ADEX Puerto Rico LLC — both companies that offer turnkey wireless and wireline telecom services and project professional and technical staffing — in early 2018. ADEX has been in operation since 1993 supporting international telecommunications companies throughout project life cycles of existing and next-generation network deployments (http://ibn.fm/xus0H).

Now ADEX Canada has been formed to address network-infrastructure service opportunities with both new and existing tier-1 clients in the Canadian market. The subsidiary will offer turnkey professional service solutions that include engineering, furnishing, installation, testing and integration services for wireline, wireless, broadband, VoIP, 4G/5G and public-safety communications networks. ADEX service capabilities extend from the most basic installation functions to the most advanced engineering challenges, which allows companies to increase the capabilities of their existing departments without having to add personnel, facilities or equipment.

Tier-1 telecommunications companies build and own the basic infrastructure of the internet, such as the undersea cables that connect the United States and Europe. In the U.S. internet region, the present tier-1 club is an elite group of five companies consisting of AT&T, Century Link (which has absorbed Qwest and Global Crossing), NTT/Verio, Sprint (Softbank Broadband) and Verizon (http://ibn.fm/AeM2e).

Spectrum recently won a key two-year, nationwide, engineering-services contract to support a tier-1 infrastructure aggregator’s 5G project. The contract is for outside plant-engineering services surrounding an optical, fiber-fed, 200+ site, metropolitan-area, 5G infrastructure deployment (http://ibn.fm/GB69w).

AW Solutions Inc. and AW Solutions Puerto Rico LLC provide best-in-class communications infrastructure deployment services to carriers, OEMs, PMOs, utilities and enterprise clients by offering full turnkey wireless and wireline service solutions. AW Solutions holds professional engineering licenses in all contiguous states and Hawaii as well as in the District of Columbia; the Canadian provinces of British Columbia, Quebec, Ontario, Alberta, Newfoundland and Labrador; and in Puerto Rico, Guam and the U.S. Virgin Islands.

Tropical Communications Inc. is a state-licensed electrical and underground utility contractor headquartered in Miami, Florida, that has been in operation since 1984. The company provides all types of communications and structured wiring services and solutions for facility infrastructure.

TNS Inc. is a Des Plaines, Illinois-based company that offers design, installation and maintenance of structured cabling-system solutions to the enterprise market. With its operations nationwide and abroad, TNS has been supporting telecommunication networks for more than 16 years.

Through its subsidiaries, Spectrum Global Solutions has developed into a comprehensive, single-source provider of professional services and solutions specializing in the development, deployment and maintenance of wireline, wireless, Distributed Antenna System (DAS), small cell, and fiber networks and infrastructure. The company’s services range in scope from a single activity to multiyear, multi-region, large-scale turnkey development contracts with a deepening pool of international, national, regional and local clients. Spectrum Global Solutions has completed more than 150,000 project activities on wireless, DAS, wireline and fiber networks across the United States by utilizing licensed professional engineers, project managers, technicians and general contractors.

For more information, visit the company’s website at www.SpectrumGlobalSolutions.com

NOTE TO INVESTORS: The latest news and updates relating to SGSI are available in the company’s newsroom at http://ibn.fm/SGSI

• CIIX has carved out unique niche in Chinese-speaking markets, is applying similar business model to rapidly growing CBD industry
• Focused on China’s emerging industrial hemp and CBD market, which is predicted to reach over $20 billion by 2022
• Meeting with companies, executives, and investors at conferences in Shanghai and Haerbing, China

ChineseInvestors.com Inc. (OTCQB: CIIX) is a leading financial news platform for the global Chinese-speaking community. The company offers real-time financial information in Chinese language character sets. By concentrating on the Chinese-speaking markets, CIIX has carved out its own unique niche. This same business model is being applied to the burgeoning cannabidiol (CBD)-based nutrition and health industry.

Early on, CIIX recognized opportunities in the U.S. cannabis industry and began laying groundwork to capitalize on the demand for quality CBD products in the Chinese-speaking community. The wholly owned subsidiary CBD Biotech Inc. was created to allow CIIX to focus on investor education products and services. The company has already established itself with the first Chinese-language CBD store online, a CBD pop-up kiosk in Glendale Galleria Mall in California, and the launch of its rebranded CBD consumer product line. Now, CBD Biotech is reaching out beyond the U.S. and is focused in on China’s emerging market, predicted to reach over $20 billion by 2022. CIIX’s CEO Warren Wang has stated that the company hopes for a Nasdaq IPO of CBD Biotech late in FY2019 or early 2020 (http://ibn.fm/bw6Q9). The company’s goal is to become the leading Chinese CBD public trading company.

Recently, the 2019 China Industrial Cannabis Investment Seminar was held in Shanghai, bringing together a myriad of companies and individuals interested in the industrial hemp market. The conference took place October 31, 2019 and was attended by CBD Biotech executives who are now gearing up to attend the 2019 China Industrial Cannabis CBD Industry International Conference in Haerbing, slated for November 23-24, 2019. Both conferences enable CBD Biotech executives to share information and education on the company’s industrial hemp-infused skincare and cosmetic products, showcase its hemp wine, feature new products soon to launch, and discuss strategic plans for future development.

As one of the first movers in this market, CBD Biotech will meet with companies and executives in China who are also active or are considering entry into the industrial hemp market. There is also ample opportunity to network with foreign industrial hemp companies, institutional investors, secondary market institutional investors, and other high net worth investors who are interested in the industrial hemp market in China. Currently, in China, there is a potential market for hemp-infused/CBD skincare and cosmetics of nearly 1.4 billion people. ChineseInvestors.com, through its subsidiary CBD Biotech, is well positioned to take advantage of this market.

To discover more about the company’s involvement in these conferences, visit http://ibn.fm/ks9m2

For more information, visit the company’s website at www.ChineseInvestors.com

NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://ibn.fm/CIIX

• ESG standard becoming important distinction in investing world
• OCLN onsite modular products offer customers water independence through ownership, operational control over water quality
• OriginClear water-treatment systems provide companies path to improving ESG standings

Deeply committed to its slogan – above and beyond clear water – OriginClear Inc. (OTC: OCLND) provides companies with much more than simply water treatment solutions. As companies opt for OCLN’s proprietary water treatment systems, they are also meeting new Environmental and Social Governance (ESG) standards, which are fast becoming an invaluable distinction in the investing world.

“ESG is a set of investing guidelines being adopted by more and more large funds, family offices, and so forth all over the world,” OCLN CEO Riggs Eckelberry explained in a news release (http://ibn.fm/xzacu). “Trillions are being invested in companies that are ESG-portfolio companies.”

A Forbes article (http://ibn.fm/Ngf5t) reported that “responsible investing is widely understood as the integration of environmental, social and governance (ESG) factors into investment processes and decision-making. ESG factors cover a wide spectrum of issues that traditionally are not part of financial analysis, yet may have financial relevance. This might include how corporations respond to climate change, how good they are with water management, how effective their health and safety policies are in the protection against accidents, how they manage their supply chains, how they treat their workers and whether they have a corporate culture that builds trust and fosters innovation.”

Choosing OriginClear makes sense on more than just the environmental level. As current infrastructure fails at providing clean water, companies must look beyond traditional solutions. OriginClear manufactures and distributes professional-grade water treatment and conveyance products for both commercial and industrial properties, including hotels and resorts, housing developments, office buildings, military installations, schools, manufacturing facilities, industry warehouses, oil and gas producers, farms and much more.

The company’s Modular Water Systems(TM) provide quick, efficient water purification, recycling, and wastewater management. OCLN’s onsite modular products offer customers water independence through ownership and operational control over water quality. OriginClear customers see increased productivity while reducing environmental, health and safety risks from pollution, contamination and corrosion.

OriginClear clients enjoy much more than onsite systems that provide purification and recycling levels that centralized systems can’t achieve. In addition to producing cleaner water, OriginClear systems can actually boost real estate asset value as a fundamental capital improvement, combined with long-lasting water savings for the corporate bottom line. And with OriginClear providing a way for organizations to improve their environmental, social and governance (ESG) standings with world-class water management, the company is in a sweet spot for water-treatment solutions.

Providing a clear solution for companies to facilitate their own water treatment, recycle water, and reduce their carbon footprint is a win in all areas. As OriginClear becomes a leader in the growing water treatment industry, the company provides exciting possibilities for potential investors evaluating opportunities that reach beyond the bottom line and meet ESG standards. “As evidence has grown that ESG issues have financial implications, the tide has shifted,” the Forbes article reported. “In many important markets, including the U.S. and the EU, ESG integration is increasingly seen as part of fiduciary duty.”

OriginClear is a leading provider of water treatment solutions. OCLN offers breakthrough water treatment and conveyance products that effectively improve the quality of the planet’s waters by returning them to their original and clear condition. To accomplish this, OriginClear deploys advanced technologies at the point of use with modular, prefabricated systems that create durable assets and water independence for industry, commerce and agriculture. The company’s stated mission is to empower this global movement with modular water treatment and conveyance products that enable water independence and help make clean water available for all.

For more information, visit the company’s website at www.OriginClear.com

NOTE TO INVESTORS: The latest news and updates relating to OCLN are available in the company’s newsroom at http://ibn.fm/OCLN

• VGW to produce minimum of 2.2 million vape pens over two-year period
• The introductory line of Made By BRNT-branded vape pens to contain Valens’ proprietary formulations
• The milestone agreement represents gross revenue potential for Valens of more than $50 million

In the largest publicly announced, multiyear, white-label agreement to date for a branded finished product in the Canadian cannabis industry, Valens GroWorks Corp. (TSX.V: VGW) (OTCQX: VGWCF) announced that it has partnered with BRNT Ltd. to launch a line of cannabis vape pens in Canada.

Under the terms of the agreement, Valens—a vertically integrated provider of industry-leading extraction products and services including a diverse suite of extraction methodologies, next-generation cannabinoid delivery formats, and an ISO 17025 accredited analytical lab—will work closely with BRNT to produce a minimum of 2.2 million vape pens over an initial two-year time period (http://ibn.fm/7eAgM). The extract formulations will be developed, crafted and tested by Valens, with Valens also overseeing the filing and distribution of the product. BRNT will facilitate the hardware design and development of the vaporizer as well as national marketing and sales efforts. The line of single-source, cannabis-extract vaporizers with artfully designed hardware will be branded by BRNT and be made available exclusively through the company’s introductory vaporizer line, Made By.

“As Valens begins official production of next generation products for Cannabis 2.0, we are excited to be collaborating with BRNT to bring to market a line of differentiated, high quality, concentrate vape products for Canadian consumers,” said Valens GroWorks CEO Tyler Robson. “BRNT has shown impressive sales growth and market understanding through its ancillary offerings. In pairing their retail and product knowledge with Valens’ processing and product development capabilities we believe this provides a solid foundation to provide a product with strong consumer appeal.”

The milestone agreement represents gross revenue potential to Valens of more than $50 million in the first two years, subject to final acceptance from provincial distributors at the proposed price per unit. While the initial agreement calls for Valens to produce at least 2.2 million vape pens in two years, it also includes two successive one-year renewal options. Valens anticipates initial shipment under the agreement to occur during the first fiscal quarter of 2020.

“Valens has demonstrated a commitment to cannabis extraction on a global scale that is driven by passion and quality,” said BRNT Group CEO Simon Grigenas. “It was a natural fit for BRNT to collaborate with Valens to bring the Made By vaporizers brand to life with a partner that can mirror our globally recognized signature design aesthetic and brand development capabilities. BRNT and Valens are setting a new industry standard by creating meaningful brands and products through a focused, profitable approach, as opposed to the traditional vertical integration seen today.”

Valens GroWorks Corp. is a multi-licensed, vertically integrated cannabis company focused on being the partner of choice for leading Canadian and international cannabis brands by providing best-in-class, proprietary services including CO2, ethanol, hydrocarbon, solvent-less and terpene extraction, analytical testing, formulation and white-label product development. Valens is the largest third-party extraction company in Canada with an annual capacity of 425,000 kg of dried cannabis and hemp biomass at its purpose-built facility in Kelowna, British Columbia. The facility is currently in the process of becoming European Union (EU) Good Manufacturing Practices (GMP) compliant.

For more information, visit the company’s website at www.ValensGroWorks.com

• VPR Brands concentrates on building a portfolio of top-notch brands
• The company is contributing to job growth in the new cannabis and hemp economy
• VPR Brands emphasis is product innovation in the cannabis and nicotine verticals

VPR Brands LP (OTCQB: VPRB) is a technology holding company with a presence in multiple lucrative markets. Having built a brand family in the nicotine and cannabis verticals, its present product lineup includes accessories and vaporizers for cannabidiol (CBD), cannabis concentrates, and extracts. A multi-vertical, tiered technology holding enterprise, VPR Brands’ assets also include issued U.S. and Chinese patents for atomization-related products. These include technology for medical-marijuana vaporizers and electronic-cigarette products and components. VPRB continues to implement its effective growth strategy of enhancing its product lines, attracting new customers, and increasing sales.

Florida-based VPR Brands additionally engages in product development for the vapor or vaping market, including e-liquids. In the CBD vertical, the company cultivates an array of brands via direct sales and licensing opportunities (http://ibn.fm/ylVY9). Its brands include its flagship HoneyStick, which has become the company’s leading product and platform to increase growth across both aforementioned verticals.

VPR’s flagship CBD line—Gold Line—offers a broad product portfolio. Products from this line include pre-rolled joints, vape cartridges, edibles, CBD pens, crumble, and tinctures. The company’s other brands include Dr. Good Hemp, Krave, Helium, VaporX, and Vaporin. Recently, it exhibited its new Gold Line CBD hemp-derived product line at the National Association of Convenience Stores (NACS) Expo in Atlanta, Georgia (http://ibn.fm/g6KVn).

This strategy of cultivating a varied family of premier products is working well for VPR Brands. For investors, it’s worth noting that VPR’s Q1 2019 financial results showed increased revenues and a narrowed net loss when compared with 2018 (http://ibn.fm/p9Fjx). The company increased its quarterly revenues roughly 31 percent year-over-year to $1.3 million. Moreover, it slightly lowered its net loss from about $149,000 in 2018 to approximately $138,000 in 2019. By sticking to its foundational business strategy, VPR Brands continues to maintain strong gross operating margins above 40 percent.

Another positive consideration is that in the burgeoning cannabis and hemp industry, jobs are expanding despite regulatory uncertainties (http://ibn.fm/EUcWu). VPR Brands is contributing to this new economy as more people look for employment in the industry. Cannabis and hemp businesses, such as VPR Brands, hire people from diverse categories and skills. This multifaceted aspect of the cannabis industry—employing myriad types of people, including managers, farmworkers, horticulturists, tech-savvy people, accountants, and marketers—adds to its potential for longevity and growth.

According to HempWireNews, experts believe this employment growth resonates with hemp industry participants like VPR Brands and others. These companies—which have historically insisted that considerable economic benefits will accrue from legalizing hemp as sales grow and companies invest, make capital expenditures, and provide jobs in their communities—are being supported by current industry statistics. A recent sales report shows that this year, CBD sales are expected to surpass $1 billion. This represents 133 percent growth over 2018 sales (http://ibn.fm/tprsy). By 2024, the forecast is that sales will exceed $10 billion. Thus, the potential is there for VPR Brands to continue to grow sales while providing jobs to foster economic growth.

VPR Brands continues to innovate in the cannabis and hemp marketplace and has a distinct advantage with its experienced management team. The company increased its full-year revenues to approximately $4.6 million last year and remains on course for healthy gross operating margins. By emphasizing and adding first-class products paired with quality distribution, VPR Brands has been able to attract more customers, which has translated to increased sales. For investors, VPR Brands is a doorway to potential major ROI in two significant verticals.

For more information, visit the company’s website at www.VPRBrands.com

NOTE TO INVESTORS: The latest news and updates relating to VPRB are available in the company’s newsroom at  http://ibn.fm/VPRB

• Helomics chief technology officer speaks at inaugural UK 100,000 Genomes Project Conference
• The 100,000 Genomes Project is a UK-government project, sequenced whole genomes from National Health Service patients
• The depth of the project data is best in class, yielding useful benchmarks to help validate Helomics models

Dr. Mark Collins, chief technology officer of Predictive Oncology Inc.’s (NASDAQ: POAI) Helomics subsidiary, recently spoke at the inaugural UK 100,000 Genomes Project Conference. Collins presented initial findings from Helomics’ analysis of UK 100,000 Genomes Project (“UK100K GP”) data toward Helomics’ goal of building AI-driven predictive models of ovarian cancer. The inaugural conference was hosted by Genomics England on November 4 in London.

According to Global Market Insights Inc., the precision medicine market is forecast to reach more than $96 billion by 2024. Helomics is an innovative precision-medicine company positioned for growth in this growing market. A subsidiary of Predictive Oncology, Helomics is dedicated to improving the standard of care for cancer patients by harnessing the power of a patient’s own living tumor to build multi-omics AI-driven predictive models of tumor drug response to improve clinical outcomes for patients

The 100,000 Genomes Project is a United Kingdom government endeavor that is sequencing whole genomes from National Health Service patients (http://ibn.fm/M9bGx). The project focuses on rare diseases, some common types of cancer and infectious diseases. Recruitment of participants to the 100,000 Genomes Project was completed in 2018, with the 100,000th sequence achieved in December 2018. The aim of the project is to transform health care through new diagnoses and personalized treatments.

Helomics partnered with the UK100K GP last year to bring its invaluable expertise and data to the groundbreaking research. The company is leveraging its proprietary, multi-omic database of tumor-drug-response profiles using the proven power of AI to build predictive models of ovarian cancer. The goal is for these AI-driven predictive models to be used by clinicians to individualize treatment options and by pharma researchers to develop new targeted therapies in the quest to improve outcomes for women with ovarian cancer.

“This partnership is key to our approach of building AI-driven predictive models,” said Collins. “We are delighted to participate in the scientific session, panel discussion and an invite-only session on the expansion of the UK 100,000 Genomes Project to 5 million genomes. The depth of both the genomic and clinical data for ovarian cancer from the project is best in class, yielding useful benchmarks to validate our models. Over the next year, we intend to explore additional projects to enable use of our AI-driven predictive models to improve outcomes for ovarian cancer patients in the UK, as well as seek partnerships with UK pharma companies for the development of new precision ovarian cancer therapies.”

In addition to speaking during the scientific session of the conference, Collins also participated in an invitation-only session focused on the expansion of the UK 100K GP to 5 million genomes.

Based in Eagan, Minnesota, Predictive Oncology operates through three business units: Helomics, TumorGenesis and Skyline Medical. Predictive Oncology works together with the pharmaceutical, diagnostic and biotechnology industries to develop highly customizable assessment methods that can lead to more effective treatments for patients. Predictive Oncology continues to take advantage of the synergies of its subsidiaries to bring precision medicine to the treatment of cancer. The company is at the vanguard of innovation in using AI in improving outcomes for cancer patients. For investors, Predictive Oncology offers the potential for significant ROI as it focuses on improving patient outcomes.

For more information, visit the company’s website at www.Predictive-Oncology.com

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI